Skip to main content

Advertisement

SpringerLink
Log in

Permeation Enhancer-Containing Water-In-Oil Nanoemulsions as Carriers for Intravesical Cisplatin Delivery

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

In the present work, we developed water-in-oil (w/o) nanoemulsions for the intravesical administration of cisplatin.

Methods

The nanoemulsions were made up of soybean oil as the oil phase and Span 80, Tween 80, or Brij 98 as the emulsifier system. α-Terpineol and oleic acid were incorporated as permeation enhancers. The physicochemical characteristics of droplet size, zeta potential, and viscosity were determined. Nanoemulsions were administered intravesically for 1 ~ 4 h to rats in vivo. Animals were subsequently sacrificed, and the bladders were harvested to examine drug accumulation and histology.

Results

Ranges of the mean size and zeta potential were 30 ~ 90 nm and −3.4 to −9.3 mV, respectively. The addition of enhancers further reduced the size of the nanoemulsions. The viscosity of all systems exhibited Newtonian behavior. The cisplatin-loaded nanoemulsions were active against bladder cancer cells. The nanoemulsions with Brij 98 exhibited the complete inhibition of cell proliferation. The encapsulation of cisplatin and carboplatin, another derivative of cisplatin, in nanoemulsions resulted in slower and more-sustained release. The amount of drug which permeated into bladder tissues significantly increased when using carriers containing Brij 98, with the α-terpineol-containing formulation showing the best result. The nanoemulsion with α-terpineol prolonged the duration of higher drug accumulation to 3 ~ 4 h. At the later stage of administration (3 ~ 4 h), this system increased the bladder wall deposition of cisplatin and carboplatin by 2.4 ~ 3.3-fold compared to the control solution. Histological examination of the urothelium showed near-normal morphology in rats instilled with these nanoemulsions. α-Terpineol possibly caused slight desquamation of umbrella cells.

Conclusions

The nanoemulsions are feasible to load cisplatin for intravesical drug delivery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Nagabhushan TL, Maneval DC, Benedict WF, Wen SF, Ihnat PM, Engler H, et al. Enhancement of intravesical delivery with Syn3 potentiates interferon-alpha2b gene therapy for superficial bladder cancer. Cytokine Growth Factor Rev. 2007;18:389–394.

    Article  PubMed  Google Scholar 

  2. Avritscher EB, Cooksley CD, Grossman HB, Sabichi AL, Hamblin L, Dinney CP, et al. Clinical model of lifetime cost of treating bladder cancer and associated complications. Urology. 2006;68:549–553.

    Article  PubMed  Google Scholar 

  3. Witjes JA, Hendricksen K. Intravesical pharmacotherapy for non-muscle-invasive bladder cancer: a critical analysis of currently available drugs, treatment schedules, and long-term results. Eur Urol. 2008;53:45–52.

    Article  PubMed  Google Scholar 

  4. Skinner E. Will a new intravesical chemotherapy agent improve the treatment of non-muscle-invasive bladder cancer? Nat Clin Pract Urol. 2007;4:248–249.

    Article  PubMed  Google Scholar 

  5. Shen Z, Shen T, Wientjes MG, O’Donnell MA, Au JLS. Intravesical treatments of bladder cancer: review. Pharm. Res. 2008;25:1500–1510.

    Article  PubMed  Google Scholar 

  6. Lu Z, Yeh TK, Tsai M, Au JLS, Wientjes MG. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res. 2004;10:7677–7684.

    Article  PubMed  Google Scholar 

  7. Tyagi P, Wu PC, Chancellor M, Yoshimura N, Huang L. Recent advances in intravesical drug/gene delivery. Mol. Pharmaceut. 2006;3:369–379.

    Article  Google Scholar 

  8. Pectasides D, Pectasides M, Economopoulos T. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer. Cancer Treat Rev. 2006;32:456–470.

    Article  PubMed  Google Scholar 

  9. Saxena S, Agrawal U, Agarwal A, Murthy NS, Mohanty K. Adjuvant intravesical therapy based on an in vitro cytotoxicity assay in the management of superficial transitional cell cancer of the urinary bladder. BJU Int. 2006;98:1012–1017.

    Article  PubMed  Google Scholar 

  10. Hadaschik BA, ter Borg MG, Jackson J, Sowery RD, So AI, Burt HM, et al. Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer. BJU Int. 2008;101:1347–1355.

    Article  PubMed  Google Scholar 

  11. Wu H, Ramachandran C, Bielinska AU, Kingzett K, Sun R, Weiner ND, et al. Topical transfection using plasmid DNA in a water-in-oil nanoemulsion. Int J Pharm. 2001;221:23–34.

    Article  PubMed  Google Scholar 

  12. Wang JJ, Hung CF, Yeh CH, Fang JY. The release and analgesic activities of morphine and its ester prodrug, morphine propionate, formulated by water-in-oil nanoemulsions. J Drug Target. 2008;16:294–301.

    Article  PubMed  Google Scholar 

  13. Giannantoni A, Di Stasi SM, Chancellor MB, Costantini E, Porena M. New frontiers in intravesical therapies and drug delivery. Eur Urol. 2006;50:1183–1193.

    Article  PubMed  Google Scholar 

  14. Kirchmann H, Pettersson S. Human urine: chemical composition and fertilizer use efficiency. Nutr Cycl Agroecosyst. 1994;40:149–154.

    Google Scholar 

  15. Burgués Gasión JP, Jiménez Cruz JF. Improving efficacy of intravesical chemotherapy. Eur Urol. 2006;50:225–234.

    Article  Google Scholar 

  16. Wang J, Maitani Y, Takayama K. Antitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol, and PEG-lipid. J Pharm Sci. 2002;91:1128–1134.

    Article  PubMed  Google Scholar 

  17. Hung CF, Fang CL, Liao MH, Fang JY. The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion. Int J Pharm. 2007;335:193–202.

    Article  PubMed  Google Scholar 

  18. Hung CF, Chen JK, Liao MH, Lo HM, Fang JY. Development and evaluation of emulsion-liposome blends for resveratrol delivery. J Nanosci Nanotechnol. 2006;6:2950–2958.

    Article  PubMed  Google Scholar 

  19. Hurst RE, Zebrowski R. Identification of proteoglycans present at high density on bovine and human bladder luminal surface. J Urol. 1994;152:1641–1644.

    PubMed  Google Scholar 

  20. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45:89–121.

    Article  PubMed  Google Scholar 

  21. Stefaniak M, Niestrój A, Klupsch J, Śliwiok J, Pyka A. Use of RP-TLC to determine the log P values of isomers of organic compounds. Chromatographia. 2005;62:87–89.

    Article  Google Scholar 

  22. Buszello K, Harnisch S, Müller RH, Müller BW. The influence of alkali fatty acids on the properties and the stability of parenteral o/w emulsions modified with Solutol HS15®. Eur J Pharm Biopharm. 2000;49:143–149.

    Article  PubMed  Google Scholar 

  23. Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ. Nano-emulsions. Curr Opin Colloid Interface Sci. 2005;10:102–110.

    Article  Google Scholar 

  24. Ayannides CA, Ktistis G. A rheological study on microemulsion gels of isopropyl myristate, polysorbate 80, glycerol, and water. J Cosmet Sci. 1999;50:1–7.

    Google Scholar 

  25. Karasulu HY, Karabulut B, Göker E, Güneri T, Gabor F. Controlled release of methotrexate from w/o microemulsion and its in vitro antitumor activity. Drug Deliv. 2007;14:225–233.

    Article  PubMed  Google Scholar 

  26. Hatefi A, Amsden B. Camptothecin delivery methods. Pharm Res. 2002;19:1389–1399.

    Article  PubMed  Google Scholar 

  27. Fang JY, Hung CF, Hua SC, Hwang TL. Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytotoxicity against cancer cells. Ultrasonics. 2009;49:39–46.

    Article  PubMed  Google Scholar 

  28. Kim JH, Kim YS, Park K, Lee S, Nam HY, Min KH, et al. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. J Control Release. 2008;127:41–49.

    Article  PubMed  Google Scholar 

  29. Yotsuyanagi T, Usami M, Noda Y, Nagata M. Computational consideration of cisplatin hydrolysis and acid dissociation in aqueous media: effect of total drug concentrations. Int J Pharm. 2002;246:95–104.

    Article  PubMed  Google Scholar 

  30. Hwang TL, Lee WR, Hua SC, Fang JY. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas. J Dermatol Sci. 2007;46:11–20.

    Article  PubMed  Google Scholar 

  31. Chung H, Kim TW, Kwon M, Kwon IC, Jeong SY. Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system. J Control Release. 2001;71:339–350.

    Article  PubMed  Google Scholar 

  32. Yoshioka T, Florence AT. Vesicle (noisome)-in-water-in-oil (v/w/o) emulsions: an in vitro study. Int J Pharm. 1994;108:117–123.

    Article  Google Scholar 

  33. Paolino D, Ventura CA, Nisticò S, Puglisi G, Fresta M. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm. 2002;244:21–31.

    Article  PubMed  Google Scholar 

  34. Bjerregaard S, Söderberg I, Vermehren C, Frokjaer S. Formulation and evaluation of release and swelling mechanism of a water-in-oil emulsion using factorial design. Int J Pharm. 1999;193:1–11.

    Article  PubMed  Google Scholar 

  35. Bjerregaard S, Söderberg I, Vermehren C, Frokjaer S. The effect of controlled osmotic stress on release and swelling properties of a water-in-oil emulsion. Int J Pharm. 1999;183:17–20.

    Article  PubMed  Google Scholar 

  36. Konishi M, Tabata Y, Kariya M, Hosseinkhani H, Suzuki A, Fukuhara K, et al. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release. 2005;103:7–19.

    Article  PubMed  Google Scholar 

  37. Grabnar I, Bogataj M, Belič A, Logar V, Karba R, Mrhar A. Kinetic model of drug distribution in the urinary bladder wall following intravesical instillation. Int J Pharm. 2006;322:52–59.

    Article  PubMed  Google Scholar 

  38. Tadros T, Izquierdo P, Esquena J, Solans C. Formulation and stability of nano-emulsions. Adv Colloid Interface Sci. 2004;108–109:303–318.

    Article  PubMed  Google Scholar 

  39. Grabnar I, Bogataj M, Mrhar A. Influence of chitosan and polycarbophil on permeation of a model hydrophilic drug into the urinary bladder wall. Int J Pharm. 2003;256:167–173.

    Article  PubMed  Google Scholar 

  40. Kerec M, Boqataj M, Veranič P, Mrhar A. Permeability of pig urinary bladder wall: the effect of chitosan and the role of calcium. Eur J Pharm Sci. 2005;25:113–121.

    Article  PubMed  Google Scholar 

  41. Godwin DA, Michniak BB. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev Ind Pharm. 1999;25:905–915.

    Article  PubMed  Google Scholar 

  42. dos Anjos JL, Alonso A. Terpenes increase the partitioning and molecular dynamics of an amphipathic spin label in stratum corneum membranes. Int J Pharm. 2008;350:103–112.

    Article  PubMed  Google Scholar 

  43. Sylvester RJ, Oosterlinck W, Witjes JA. The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials. Eur Urol. 2008;53:709–719.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cell Pharmacology Laboratory, Graduate Institute of Natural Products, Chang Gung University, Kweishan, Taoyuan, Taiwan

    Tsong-Long Hwang

  2. Department of Pathology, College of Medicine, Taipei Medical University, Taipei, Taiwan

    Chia-Lang Fang

  3. Pharmaceutics Laboratory, Graduate Institute of Natural Products, Chang Gung University, 259 Wen-Hwa 1st Road, Kweishan, Taoyuan 333, Taiwan

    Chao-Huang Chen & Jia-You Fang

Authors
  1. Tsong-Long Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chia-Lang Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chao-Huang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jia-You Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jia-You Fang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hwang, TL., Fang, CL., Chen, CH. et al. Permeation Enhancer-Containing Water-In-Oil Nanoemulsions as Carriers for Intravesical Cisplatin Delivery. Pharm Res 26, 2314–2323 (2009). https://doi.org/10.1007/s11095-009-9947-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-009-9947-6

Key words

Search

Navigation